Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Greenlane Renewables Extends CA$20 Million Credit Facility

Greenlane Renewables Extends CA$20 Million Credit Facility

MT newswireMT newswire2026/10/06 13:15

09:15 AM EDT, 10/06/2026 (MT Newswires) -- Greenlane Renewables (GRN.TO) extended its CA$20 million standby letter of credit facility to Sept. 30, 2027, supporting the company's ability to pursue new system sales. The facility is secured by a guarantee from Export Development Canada, the company said Tuesday. Greenlane said the facility will help the company meet requirements by some system sales contracts to provide letters of credit or other financial assurances. The facility allows Greenlane to comply with these requirements while preserving cash reserves, the company said. Greenlane shares closed down CA$0.015, or 8.6%, to CA$0.16 Monday on the Toronto Stock Exchange.

09:15 AM EDT, 10/06/2026 (MT Newswires) -- Greenlane Renewables (GRN.TO) extended its CA$20 million standby letter of credit facility to Sept. 30, 2027, supporting the company's ability to pursue new system sales. The facility is secured by a guarantee from Export Development Canada, the company said Tuesday. Greenlane said the facility will help the company meet requirements by some system sales contracts to provide letters of credit or other financial assurances. The facility allows Greenlane to comply with these requirements while preserving cash reserves, the company said. Greenlane shares closed down CA$0.015, or 8.6%, to CA$0.16 Monday on the Toronto Stock Exchange.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21